Who should attend
The masterclass is relevant for both SMEs and larger industrial players. It addresses managers with executive or operational responsibilities for identifying, shaping and developing digital innovations in healthcare. The masterclass is also of interest for other stakeholders in the innovation supply chain, such as public organisations on both local, regional and federal level, private and public healthcare institutions, NGOs etc.
About the course
Understand the changing landscape of digital healthcare, find new business opportunities and learn tools for more valuable and robust innovations.
New digital products and solutions are at the center of an emerging transformation of healthcare. Companies entering and competing in this environment need to understand this changing landscape.
Changes redefine the opportunities and the context for innovations and the way innovations must be developed to become competitive. From this masterclass participants obtain a deeper and more actionable understanding of key changes in the landscape. With help from university and industry experts they learn and practice crucial tools to make their innovations more competitive.
After the masterclass you will be able to:
- Direct your innovation efforts more effectively in the changing landscape of digital healthcare.
- Analyse, compare the way platforms in digital health shape and affect the innovation agenda of their
- Better understand the changing context defined by these platforms for third party innovating firms, their
- options and their need for an innovation strategy.
- Unpack the conditions for start-ups and novel solutions in Danish Digital Health. See the differentiating
- factors between success and failure for entrepreneurs in digital health.
- Understand the strategy and processes of digital innovation in large pharma and medtech firms, and their
- success in creating digital connectivity though multiple alliances
- See the ways large healthcare firms undertake global scouting and sourcing of emerging technologies and solutions
The course content focus on five broad topics:
- New technologies and business strategies are opening new arenas for digital health. One example are the patient support platforms introduced by pharmaceutical firms. We identify their challenges of securing patient involvement and retention and examine platform design solutions that have been successful. Another example is artificial intelligence (AI). Innovating companies often meet challenges in implementation, in finding user acceptance and in designing appropriate business models for AI solutions. We examine a case by bringing to the classroom both the innovating AIcompany and the user organisation.
- How do platforms shape competition in digital health? We invite innovators of platforms into the programme. We also study platforms designed for hospital management in developing economies, as examples of the way companies can innovate their way into emerging markets in digital health.
- Public policy, procurement and regulation shape important parts of the innovation landscape in digital health. We examine the implications of these policies on digital health innovation in the Danish case, including firms directly involved in innovations responding to the strategy. We zoom in on the factors affecting success or failure in digital health innovation.
- Large pharma and medtech companies play a critical role in moving digital solutions forward. Combining internal capabilities with external sourcing and partnerships allow them to overcome the many complexities of digital health care innovation. With experts from Novo Nordisk we examine the 2019 introduction of the connected NovoPen® 6, and the alliance with multiple partners underpinning its connectivity.
- To stay at the frontier of digital innovation, large pharma and medtech companies invest in global scouting and monitoring of emerging technologies and solutions, with a focus not least on Silicon Valley and China. We examine their efforts and prioritisation in their global technology scouting.
Finn Valentin is professor at Copenhagen Business School where he directs its Research Centre on Biotech Business. He is the Director of the MSc program on Innovation in Health care and of the MSc program on BioBusiness and Innovation. Finn Valentin’s research is about science-based firms innovat...
Søren Brunak is a leading pioneer in the biomedical sciences through invention and introduction of new computational strategies for analysis of biomedical data for use in molecular biology, medicine and biotechnology. His main achievements can be divided into two categories: 1) new, advanced bioi...
Enthusiastic pharmaceutical business development professional with a passion for leading people and extensive experience in creative deal making in big pharma including technical and commercial evaluation of products, technologies and businesses with solid track record of completed deals. Experie...
Anders Dyhr Toft’s journey to pharma nirvana started in an unusual place: on a rescue helicopter in the French Alps. An avid skier, Toft spent three winters jetting among 14 resorts in the region, providing emergency medical care to individuals injured on the slope. While he passed his summers in...
Nanna Skovgaard is head of division in the Danish Ministry of Health, division of data, infrastructure and cyber security. Her main focus is implementation, benefit realization and steering mechanisms in health management. On behalf of the Danish Ministry of Health, Nanna Skovgaard has been a key...
Claus, our health data specialist, spent most of his professional life building Rehfeld Partners - the largest Health Business Intelligence company in Denmark. Since selling his company in 2016 he has become an active investor in life science. Experience Co-Founder and Health data specialist Co...
Today’s pace of innovation requires strategies that enable established companies to navigate disruptive change and identify new lines of business. This means a need for structures that increase their ability to do disruptive innovation at speed and scale in parallel with ‘business as usual’. I p...
Roeen Roashan is a Senior Analyst in the Healthcare Technology research team. His specific area of coverage is digital health, where he has developed an industry-leading intelligence service on topics such as consumer medical devices, virtual healthcare and wearable technologies. Roeen has been q...
Andreas Cleve is the co-founder and CEO of Corti, which provides live decision assistance to emergency call takers built on state-of-the-art artificial intelligence. Andreas is a serial-entrepreneur in the healthcare space. He previously co-founded and later sold the NLP startup Ovivo in 2013, w...
Daniel Gewecke Daugaard M.Sc. in Economics and Business Administration, Management of Innovation and Business Development. Daniel is the Director of Trifork eHealth. He comes from a background in entrepreneurship and from the pharmaceutical industry, working with innovation and patient centric se...
Videos and materials
Because of COVID-19, many providers are cancelling or postponing in-person programs or providing online participation options.
We are happy to help you find a suitable online alternative.